𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Neuroprotective Therapy for Parkinson's Disease

✍ Scribed by William C. Koller

Book ID
115606460
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
64 KB
Volume
144
Category
Article
ISSN
0014-4886

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Neuroprotective Therapy for Parkinson's
Neuroprotective Therapy for Parkinson's disease
✍ I.Shoulson and the Parkinson Study Group πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 103 KB πŸ‘ 1 views

In the context of degenerative disorders of the basal ganglia, neuroprotective therapy refers to interventions that preserve the integrity and function of vulnerable neurons and thereby slow or halt clinical decline. Decoppering therapy for Wilson's disease is the only established neuroprotective th

A rationale for monoamine oxidase inhibi
A rationale for monoamine oxidase inhibition as neuroprotective therapy for parkinson's disease
✍ Prof. C. W. Olanow πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 719 KB

Neurons in the substantia nigra may be vulnerable to oxidant stress because (a) the metabolism of dopamine generates peroxides. which, in the presence of iron. can lead to the formation of the highly reactive hydroxyl free radical; and (b) neuromelanin within nigral neurons can bind metals such as i

Neuroprotective therapy in Parkinson's d
Neuroprotective therapy in Parkinson's disease and motor complications: A search for a pathogenesis-targeted, disease-modifying strategy
✍ C. Warren Olanow; Joseph Jankovic πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 78 KB πŸ‘ 1 views

The introduction of levodopa in the late 1960s represented a landmark in the therapy of Parkinson's disease (PD). However, motor complications of chronic levodopa therapy have emerged as a major limitation of this otherwise effective therapy. Advancing medical and surgical treatment of these complic